US$ 27.58
epithalon peptide mechanism of action AEDG (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Improving Biological Age, Telomere Length,
Description
K.RingstadG

MS confirmation is the only way to verify the compound is structurally correct

KCNQ-specific blockers (Chromanol 293B, XE991) reversed, and activators (retigabine, ICA 69673) mimicked in vitro OIRD

Pharmacokinetic studies in rats demonstrated an oral bioavailability of 38.4%, with a mean Cmax of 2,252 ng/mL and terminal elimination half-lives of 3.80 1.10 hours (IV) and 6.90 1.20 hours (oral) (Awosemo et al., 2021)
